Acute Kidney Injury in Hospitalized Patients with COVID-19

Author:

Chan Lili,Chaudhary Kumardeep,Saha Aparna,Chauhan Kinsuk,Vaid Akhil,Baweja Mukta,Campbell Kirk,Chun Nicholas,Chung Miriam,Deshpande Priya,Farouk Samira S.,Kaufman Lewis,Kim Tonia,Koncicki Holly,Lapsia Vijay,Leisman Staci,Lu Emily,Meliambro Kristin,Menon Madhav C.,Rein Joshua L.,Sharma Shuchita,Tokita Joji,Uribarri Jaime,Vassalotti Joseph A.,Winston Jonathan,Mathews Kusum S.,Zhao Shan,Paranjpe Ishan,Somani Sulaiman,Richter Felix,Do Ron,Miotto Riccardo,Lala Anuradha,Kia Arash,Timsina Prem,Li Li,Danieletto Matteo,Golden Eddye,Glowe Patricia,Zweig Micol,Singh Manbir,Freeman Robert,Chen Rong,Nestler Eric,Narula Jagat,Just Allan C.,Horowitz Carol,Aberg Judith,Loos Ruth J.F.,Cho Judy,Fayad Zahi,Cordon-Cardo Carlos,Schadt Eric,Levin Matthew A.,Reich David L.,Fuster Valentin,Murphy Barbara,He John Cijiang,Charney Alexander W.,Böttinger Erwin P.,Glicksberg Benjamin S.,Coca Steven G.,Nadkarni Girish N.

Abstract

ABSTRACTImportancePreliminary reports indicate that acute kidney injury (AKI) is common in coronavirus disease (COVID)-19 patients and is associated with worse outcomes. AKI in hospitalized COVID-19 patients in the United States is not well-described.ObjectiveTo provide information about frequency, outcomes and recovery associated with AKI and dialysis in hospitalized COVID-19 patients.DesignObservational, retrospective study.SettingAdmitted to hospital between February 27 and April 15, 2020.ParticipantsPatients aged ≥18 years with laboratory confirmed COVID-19ExposuresAKI (peak serum creatinine increase of 0.3 mg/dL or 50% above baseline).Main Outcomes and MeasuresFrequency of AKI and dialysis requirement, AKI recovery, and adjusted odds ratios (aOR) with mortality. We also trained and tested a machine learning model for predicting dialysis requirement with independent validation.ResultsA total of 3,235 hospitalized patients were diagnosed with COVID-19. AKI occurred in 1406 (46%) patients overall and 280 (20%) with AKI required renal replacement therapy. The incidence of AKI (admission plus new cases) in patients admitted to the intensive care unit was 68% (553 of 815). In the entire cohort, the proportion with stages 1, 2, and 3 AKI were 35%, 20%, 45%, respectively. In those needing intensive care, the respective proportions were 20%, 17%, 63%, and 34% received acute renal replacement therapy. Independent predictors of severe AKI were chronic kidney disease, systolic blood pressure, and potassium at baseline. In-hospital mortality in patients with AKI was 41% overall and 52% in intensive care. The aOR for mortality associated with AKI was 9.6 (95% CI 7.4-12.3) overall and 20.9 (95% CI 11.7-37.3) in patients receiving intensive care. 56% of patients with AKI who were discharged alive recovered kidney function back to baseline. The area under the curve (AUC) for the machine learned predictive model using baseline features for dialysis requirement was 0.79 in a validation test.Conclusions and RelevanceAKI is common in patients hospitalized with COVID-19, associated with worse mortality, and the majority of patients that survive do not recover kidney function. A machine-learned model using admission features had good performance for dialysis prediction and could be used for resource allocation.Key PointsQuestionWhat is incidence and outcomes of acute kidney injury (AKI) in patients hospitalized with COVID-19?FindingsIn this observational study of 3,235 hospitalized patients with COVID-19 in New York City, AKI occurred in 46% of patients and 20% of those patients required dialysis. AKI was associated with increased mortality. 44% of patients discharged alive had residual acute kidney disease. A machine learned predictive model using baseline features for dialysis requirement had an AUC Of 0.79.MeaningAKI was common in patients with COVID-19, associated with increased mortality, and nearly half of patients had acute kidney disease on discharge.

Publisher

Cold Spring Harbor Laboratory

Reference22 articles.

1. Su H , Yang M , Wan C , et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int. 2020.

2. Guan WJ , Ni ZY , Hu Y , et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020.

3. icnarc. ICNARC report on COVID-19 in critical care. https://www.icnarc.org/Our-Audit/Audits/Cmp/Reports. Published 2020. Accessed.

4. Abelson R , Fink S , Kulish N , Thomas K . An Overlooked, Possibly Fatal Coronavirus Crisis: A Dire Need for Kidney Dialysis. New York Times. https://www.nytimes.com/2020/04/18/health/kidney-dialysis-coronavirus.html. Published 2020. Accessed.

5. Goldfarb DS , Benstein JA , Zhdanaova O , et al. Impending Shortages of Kidney Replacement Therapy for COVID-19 Patients. Clinical Journal of the American Society of Nephrology. 2020.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3